Player FM ऐप के साथ ऑफ़लाइन जाएं!
#14 Advancing pharmacovigilance in Africa – Eleni Aklillu & Abbie Barry
Manage episode 424661254 series 2749727
Access to medical products has increased considerably in Africa in recent years, but safety monitoring systems haven’t exactly kept pace and many African countries still struggle to address safety issues. We sat down with Eleni Aklillu and Abbie Barry of the PROFORMA project to learn about their efforts to strengthen pharmacovigilance capacity in East Africa – especially within public health programmes.
Tune in to find out:
- How comorbidities and genetic variation affect drug safety monitoring
- Why pharmacovigilance centres should strengthen their ties with academia
- How to apply the PROFORMA model elsewhere
Want to know more?
- Low- and middle-income countries like the PROFORMA target nations face unique challenges in establishing robust pharmacovigilance systems, as described in this comprehensive review.
- PROFORMA’s baseline assessment of national pharmacovigilance systems in Ethiopia, Kenya, Rwanda, and Tanzania identified gaps and laid the groundwork for targeted interventions.
- Their subsequent assessment of pharmacovigilance capacity within the neglected tropical diseases programmes highlighted the urgent need for collaboration between those programmes and the national pharmacovigilance centres.
- You can read about PROFORMA’s accomplishments in more detail on Uppsala Reports and on the PROFORMA website, which also lists the consortium’s publications and upcoming events.
For more on the influence of genetic factors on drug response, revisit this interview with UMC’s pharmacogenetics specialist Qun-Ying Yue or this Uppsala Reports Long Read on pharmacogenomics research in Africa.
Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.
52 एपिसोडस
Manage episode 424661254 series 2749727
Access to medical products has increased considerably in Africa in recent years, but safety monitoring systems haven’t exactly kept pace and many African countries still struggle to address safety issues. We sat down with Eleni Aklillu and Abbie Barry of the PROFORMA project to learn about their efforts to strengthen pharmacovigilance capacity in East Africa – especially within public health programmes.
Tune in to find out:
- How comorbidities and genetic variation affect drug safety monitoring
- Why pharmacovigilance centres should strengthen their ties with academia
- How to apply the PROFORMA model elsewhere
Want to know more?
- Low- and middle-income countries like the PROFORMA target nations face unique challenges in establishing robust pharmacovigilance systems, as described in this comprehensive review.
- PROFORMA’s baseline assessment of national pharmacovigilance systems in Ethiopia, Kenya, Rwanda, and Tanzania identified gaps and laid the groundwork for targeted interventions.
- Their subsequent assessment of pharmacovigilance capacity within the neglected tropical diseases programmes highlighted the urgent need for collaboration between those programmes and the national pharmacovigilance centres.
- You can read about PROFORMA’s accomplishments in more detail on Uppsala Reports and on the PROFORMA website, which also lists the consortium’s publications and upcoming events.
For more on the influence of genetic factors on drug response, revisit this interview with UMC’s pharmacogenetics specialist Qun-Ying Yue or this Uppsala Reports Long Read on pharmacogenomics research in Africa.
Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.
52 एपिसोडस
सभी एपिसोड
×![Artwork](/static/images/128pixel.png)
1 #35 Veterinary pharmacovigilance part 2 – James Mount 41:42
![Artwork](/static/images/128pixel.png)
1 #34 Veterinary pharmacovigilance, Part I – James Mount 47:21
![Artwork](/static/images/128pixel.png)
1 #33 Narrative fields and signal assessors, an exploratory study – Joana Félix and Alem Zekarias 38:43
![Artwork](/static/images/128pixel.png)
1 #32 Pharmacovigilance in older adults – Giovanni Furlan 47:51
![Artwork](/static/images/128pixel.png)
1 #31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori 42:45
![Artwork](/static/images/128pixel.png)
1 Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects 25:02
![Artwork](/static/images/128pixel.png)
1 Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance 30:18
![Artwork](/static/images/128pixel.png)
1 #30 Preventing and reporting medication errors – Rabat CC & UMC 33:58
![Artwork](/static/images/128pixel.png)
1 #29 When medicines change our behaviour – Michele Fusaroli 30:30
![Artwork](/static/images/128pixel.png)
1 #28 Catching black swans – François Montastruc 27:21
![Artwork](/static/images/128pixel.png)
1 #27 When drugs damage the liver – Rita Baião 28:30
![Artwork](/static/images/128pixel.png)
1 #26 What's trending in pharmacovigilance? – Angela Caro 28:06
![Artwork](/static/images/128pixel.png)
1 #25 A week in the name of medicines safety – part 2 33:13
![Artwork](/static/images/128pixel.png)
1 #24 A week in the name of medicines safety – part 1 27:09
![Artwork](/static/images/128pixel.png)
1 Uppsala Reports Long Reads – The colour of signals 33:59
प्लेयर एफएम में आपका स्वागत है!
प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।